4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-018738
Chief Financial Officer acquired 20,604 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2021-03-04 | Grant or award | +20,604 | 21,604 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2021-03-04 | Grant or award · Stock Option (Right to Buy) | +51,511 | 51,511 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…